S Vandel

1.1k total citations
74 papers, 783 citations indexed

About

S Vandel is a scholar working on Psychiatry and Mental health, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, S Vandel has authored 74 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Psychiatry and Mental health, 28 papers in Pharmacology and 11 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in S Vandel's work include Treatment of Major Depression (24 papers), Electroconvulsive Therapy Studies (12 papers) and Schizophrenia research and treatment (11 papers). S Vandel is often cited by papers focused on Treatment of Major Depression (24 papers), Electroconvulsive Therapy Studies (12 papers) and Schizophrenia research and treatment (11 papers). S Vandel collaborates with scholars based in France, Switzerland and New Zealand. S Vandel's co-authors include B Vandel, R Volmat, G Allers, Gilles Bertschy, P Bízouard, P Bechtel, D. Sechter, B Bonin, Pierre Vandel and Y. Bourezane and has published in prestigious journals such as Clinical Infectious Diseases, Psychopharmacology and Pharmacological Research.

In The Last Decade

S Vandel

69 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Vandel France 15 301 295 217 113 105 74 783
Benito J. Cerimele United States 14 257 0.9× 215 0.7× 191 0.9× 74 0.7× 102 1.0× 33 953
Allen A. Lai United States 17 108 0.4× 206 0.7× 153 0.7× 197 1.7× 127 1.2× 25 852
Carol R. Reed United States 16 342 1.1× 309 1.0× 165 0.8× 67 0.6× 93 0.9× 27 1.5k
C Crevoisier Switzerland 17 133 0.4× 148 0.5× 143 0.7× 162 1.4× 84 0.8× 40 888
Robert A. Ronfeld United States 18 236 0.8× 89 0.3× 260 1.2× 148 1.3× 90 0.9× 29 1.0k
Virginia D. Schmith United States 18 216 0.7× 191 0.6× 71 0.3× 59 0.5× 134 1.3× 49 1.2k
C. J. Timmer Netherlands 16 225 0.7× 251 0.9× 141 0.6× 155 1.4× 62 0.6× 37 1.0k
Heidi L. Liston United States 10 126 0.4× 258 0.9× 202 0.9× 194 1.7× 54 0.5× 12 712
Per T. Thyrum United States 14 130 0.4× 340 1.2× 90 0.4× 98 0.9× 58 0.6× 30 714
R. K. Nayak United States 16 280 0.9× 435 1.5× 118 0.5× 406 3.6× 112 1.1× 26 986

Countries citing papers authored by S Vandel

Since Specialization
Citations

This map shows the geographic impact of S Vandel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Vandel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Vandel more than expected).

Fields of papers citing papers by S Vandel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Vandel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Vandel. The network helps show where S Vandel may publish in the future.

Co-authorship network of co-authors of S Vandel

This figure shows the co-authorship network connecting the top 25 collaborators of S Vandel. A scholar is included among the top collaborators of S Vandel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Vandel. S Vandel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vandel, Pierre, et al.. (2000). Effets indésirables extrapyramidaux des neuroleptiques et antidépresseurs - recherche de facteurs de risque : rôle du polymorphisme génétique du CYP2D6. 26(1). 62–67. 1 indexed citations
2.
Vandel, Pierre, et al.. (1999). [Clinical tolerance of a new antidepressant -- milnacipran].. PubMed. 25(3). 252–8. 8 indexed citations
3.
Bourezane, Y., et al.. (1998). DRESS (Drug Rash with Eosinophilia and Systemic Syndrome Associated with Nevirapine Therapy. Clinical Infectious Diseases. 27(5). 1321–1322. 74 indexed citations
4.
Lima, Carlos Augusto de Mendonça, S Vandel, Bernard Bonin, P Bechtel, & Rosalı́a Carrón. (1997). [Maprotiline versus fluvoxamine: comparison of their effects on the hypothalamo-hypophyseal-thyroid axis].. PubMed. 23(1). 48–55. 9 indexed citations
5.
Bonin, Bernard, Pierre Vandel, & S Vandel. (1995). Fluvoxamine and galactorrhea. A case report.. PubMed. 49(2). 149–51. 7 indexed citations
6.
Bertschy, Gilles & S Vandel. (1993). [The link between suicide and depression. Epidemiologic aspects].. PubMed. 17(1). 33–6. 5 indexed citations
7.
Bertschy, Gilles & S Vandel. (1992). Clomipramine plasma levels among depressed outpatients in Benin, west Africa: drug compliance and comparison with Caucasian patients.. PubMed. 12(5). 334–6. 2 indexed citations
8.
Bertschy, Gilles, S Vandel, B Bonin, et al.. (1992). METABOLIC INTERACTION BETWEEN TRICYCLIC ANTIDEPRESSANT AND FLUVOXAMINE AND FLUOXETINE, A PHARMACOGENETIC APPROACH. Clinical Neuropharmacology. 15. 78A–79A. 3 indexed citations
9.
Bouquet, S., S Vandel, Gilles Bertschy, et al.. (1992). PHARMACOKINETICS OF FLUOXETINE AND FLUVOXAMINE IN DEPRESSED PATIENTS: PERSONAL RESULTS. Clinical Neuropharmacology. 15. 82A–83A. 5 indexed citations
10.
Bertschy, Gilles, S Vandel, D. Sechter, & P Bízouard. (1992). [Yawning and sexual excitation under clomipramine. Role of serotoninergic mechanisms. Apropos of 2 cases].. PubMed. 17(6). 515–7. 5 indexed citations
11.
Bertschy, Gilles, et al.. (1991). [Amineptin dependence. Detection of patients at risk. Report of 8 cases].. PubMed. 16(5). 405–9. 9 indexed citations
12.
Vandel, S, Gilles Bertschy, B Vandel, G Allers, & R Volmat. (1990). [Compliance, subdosage and overdosage of antidepressive agents in the first prescription in a hospital milieu].. PubMed. 45(2). 145–9. 1 indexed citations
13.
Bertschy, Gilles, et al.. (1990). Desipramine Induces Cardiac Beta-Adrenergic Sensitivity Decrease in Major Depressed Patients without Relationship to Therapeutic Response. Pharmacopsychiatry. 23(6). 283–286. 1 indexed citations
14.
Vandel, S, Gilles Bertschy, B Vandel, G Allers, & R Volmat. (1989). Amitriptyline: linear or nonlinear kinetics in every day practice?. European Journal of Clinical Pharmacology. 37(6). 595–598. 8 indexed citations
15.
Bertschy, Gilles, S Vandel, B Vandel, et al.. (1989). Desipramine Dose Prediction Based on 24-Hour Single-Dose Levels: Feasibility and Validity. Pharmacopsychiatry. 22(4). 161–164. 4 indexed citations
16.
Vandel, B & S Vandel. (1986). Facteurs pharmacocinétiques et résistance aux traitements antidépresseurs.. 1 indexed citations
17.
Vandel, S, et al.. (1986). Biotransformation of Amitriptyline in Man: Interaction with Phenothiazines. Neuropsychobiology. 15(1). 15–19. 7 indexed citations
18.
Vandel, B, et al.. (1982). Pharmacokinetics of viloxazine hydrochloride in man. European Journal of Drug Metabolism and Pharmacokinetics. 7(1). 65–68. 6 indexed citations
19.
Vandel, B, S Vandel, G Allers, & R Volmat. (1981). Clinical Pharmacology of Viloxazine Hydrochloride. Pharmacopsychiatry. 14(2). 66–70. 10 indexed citations
20.
Vandel, S, et al.. (1959). Incorporation in vivo du 32P dans les phospholipides du sérum de rat.. 41. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026